Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sheue‐Fen Tzeng
Observed names:
S.F. Tzeng,
Sheue-Fen Tzeng
Institution:
Taipei Medical University
Observed institutions:
Tri-Service General Hospital,
National Taiwan University,
China Medical University,
Ministry of Justice,
Agricultural Biotechnology Research Center, Academia Sinica,
Taipei Medical University,
National Defense Medical Center,
Academia Sinica,
University of Lausanne
show all 9
ORCID:
0000-0003-1126-6763
Observed ORCID:
0000-0003-1126-6763
OpenAlex ID:
A5065062397
CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions
2023
·
Pu-Ste Liu
, Yi-Ting Chen
, et al.
·
Nature Immunology
·
238
PDF
Immunoediting instructs tumor metabolic reprogramming to support immune evasion
2023
·
Chin-Hsien Tsai
, Yu-Ming Chuang
, et al.
·
Cell Metabolism
·
113
Metastatic Progression of Prostate Cancer Is Mediated by Autonomous Binding of Galectin-4- O -Glycan to Cancer Cells
2016
·
Chin-Hsien Tsai
, Sheue-Fen Tzeng
, et al.
·
Cancer Research
·
69
O ‐Glycosylation‐mediated signaling circuit drives metastatic castration‐resistant prostate cancer
2018
·
Sheue‐Fen Tzeng
, Chin‐Hsien Tsai
, et al.
·
The FASEB Journal
·
63
Curcumin-Targeting Pericellular Serine Protease Matriptase Role in Suppression of Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis
2013
·
Tai-Shan Cheng
, Wen-Chi Chen
, et al.
·
Cancer Prevention Research
·
52
PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025
·
Sheue-Fen Tzeng
, Yi-Ru Yu
, et al.
·
Cancer Discovery
·
47
PDF
A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer
2017
·
Chin-Hsien Tsai
, Sheue-Fen Tzeng
, et al.
·
Scientific Reports
·
34
Immunosurveillance encounters cancer metabolism
2024
·
Yu-Ming Chuang
, Sheue-Fen Tzeng
, et al.
·
EMBO Reports
·
31
A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells
2023
·
Yao-Wen Chang
, Huey-Wen Hsiao
, et al.
·
Cell Reports Medicine
·
19
PDF
Development of a standardized and effect-optimized herbal extract of Wedelia chinensis for prostate cancer
2015
·
Chin-Hsien Tsai
, Sheue-Fen Tzeng
, et al.
·
Phytomedicine
·
18
A Standardized Wedelia chinensis Extract Overcomes the Feedback Activation of HER2/3 Signaling upon Androgen-Ablation in Prostate Cancer
2017
·
Chin-Hsien Tsai
, Sheue-Fen Tzeng
, et al.
·
Frontiers in Pharmacology
·
14
PDF
Author Correction: CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions
2023
·
Pu-Ste Liu
, Yi-Ting Chen
, et al.
·
Nature Immunology
·
11
PDF
Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species
2026
·
Alexander J. Wesolowski
, Ardon M. Pillay
, et al.
·
Science
·
1
1205 PLT012, a humanized CD36-blocking antibody, induces durable anti-tumor immunity via immunometabolic reprogramming
2025
·
Yi-Ru Yu
, Sheue-Fen Tzeng
, et al.
·
Regular and Young Investigator Award Abstracts
·
1
PDF
Abstract 2370: Revitalizing anti-tumor immunity through PLT012 monoclonal antibody, targeting CD36 for metabolic rewiring in the tumor microenvironment
2024
·
Yi-Ru Yu
, Sheue-Fen Tzeng
, et al.
·
Cancer Research
·
1
Abstract LB-358: Abnormal O-glycosylation promotes prostate cancer stemness and mediates metastatic niche
2018
·
Chin-Hsien Tsai
, Sheue-Fen Tzeng
·
Cancer Research
·
1
Metabolic Constraints and Interactions Drive T-cell Function and Exhaustion in Cancer Progression
2026
·
Sheue-Fen Tzeng
, Chin-Hsien Tsai
·
Journal of Medical Sciences
Figure S1 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025
·
Yi-Ta Tsai
, En-Ting Liu
, et al.
Figure S11 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025
·
Yi-Ta Tsai
, En-Ting Liu
, et al.
Figure S5 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025
·
Yi-Ta Tsai
, En-Ting Liu
, et al.
Figure S12 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025
·
Yi-Ta Tsai
, En-Ting Liu
, et al.
Figure S4 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025
·
Yi-Ta Tsai
, En-Ting Liu
, et al.
Table S2 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025
·
Yi-Ta Tsai
, En-Ting Liu
, et al.
Figure S2 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025
·
Yi-Ta Tsai
, En-Ting Liu
, et al.
Figure S6 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025
·
Yi-Ta Tsai
, En-Ting Liu
, et al.
Show more works
View as search
Works count:
68
Citation count:
712
H-index:
11
I10-index:
12
Year
Topic
Type
